Table 3.
Characteristics of the rapid reviews
| Case study 1: Nivolumab for adult individuals with Hodgkin’s lymphoma | Case study 2: Early versus deferred androgen suppression for treating advanced prostate cancer | Case study 3: Unconditional cash transfers for reducing poverty and vulnerabilities | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Reviewer | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 |
| Search date |
May 24, 2017 December 08, 2017 (update search) |
July 19, 2017 | July 10, 2017 | ||||||
| Publications identified from abbreviated electronic searches | 98 | 195 | 385 | ||||||
| Additional publications identified from searches of reference lists | 1 | 0 | 2 | 2 | 1 | 9 | 49 | 2 | 9 |
| Abstracts screened | 99 | 98 | 100 | 197 | 196 | 204 | 434 | 387 | 394 |
| Excluded abstracts | 94 | 84 | 88 | 182 | 183 | 190 | 337 | 342 | 331 |
| Full texts screened | 5 | 14 | 12 | 15 | 13 | 14 | 97 | 45 | 63 |
| Excluded full texts | 2 | 11 | 7 | 4 | 5 | 4 | 54 | 22 | 37 |
| Publications included | 3 | 3 | 4 | 7 | 6 | 7 | 15 | 9 | 12 |
| Studies included | 3 | 3 | 3 | 6 | 4 | 5 | 10 | 8 | 9 |
| Studies included and identified through reference list checking | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 3 | 3 |
| Studies identified through abbreviated electronic searches but missed by single-reviewer screening | 0 | 0 | 0 | 3 | 5 | 4 | 1 | 2 | 1 |
| Studies included in meta-analyses | 0 | 0 | 0 | 6 | 4 | 5 | 6 | 4 | 6 |